Cis-regulatory mutations in human disease.
Cis-acting regulatory sequences are required for the proper temporal and spatial control of gene expression. Variation in gene expression is highly heritable and a significant determinant of human disease susceptibility. The diversity of human genetic diseases attributed, in whole or in part, to mutations in non-coding regulatory sequences is on the rise. Improvements in genome-wide methods of associating genetic variation with human disease and predicting DNA with cis-regulatory potential are two of the major reasons for these recent advances. This review will highlight select examples from the literature that have successfully integrated genetic and genomic approaches to uncover the molecular basis by which cis-regulatory mutations alter gene expression and contribute to human disease. The fine mapping of disease-causing variants has led to the discovery of novel cis-acting regulatory elements that, in some instances, are located as far away as 1.5 Mb from the target gene. In other cases, the prior knowledge of the regulatory landscape surrounding the gene of interest aided in the selection of enhancers for mutation screening. The success of these studies should provide a framework for following up on the large number of genome-wide association studies that have identified common variants in non-coding regions of the genome that associate with increased risk of human diseases including, diabetes, autism, Crohn's, colorectal cancer, and asthma, to name a few.
Epstein
Douglas J
DJ
Department of Genetics, University of Pennsylvania School of Medicine, Clinical Research Bldg, Room 470, 415 Curie Blvd, Philadelphia, PA 19104, USA. epsteind@mail.med.upenn.edu
D004194:Disease / Q000235:genetics*; D005786:Gene Expression Regulation; D006801:Humans; D009154:Mutation / Q000235:genetics*; D012045:Regulatory Sequences, Nucleic Acid / Q000235:genetics*